SOM Biotech
SOM Biotech is a late-stage clinical development company that utilizes an Artificial Intelligence platform for drug discovery. The firm focuses on identifying and developing therapies for rare central nervous system (CNS) disorders, including Huntington’s disease. Their pipeline includes compounds that have achieved positive Phase 2 clinical results, with a lead asset prepared for Phase 3 trials.
Healthtech
Biotechnology
Artificial Intelligence
Pharmaceuticals
Funding summary
- Total raised
- €7.0M
- Funding rounds
- 1
Investors in SOM Biotech
Investors on record for SOM Biotech. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like SOM Biotech?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors